This screening allowed us to identify a plasmatic signature associated with subclinical atherosclerosis specific to PLWH that included the upregulation of IL-18 and IL-1β and downregulation of TRAIL, three important proteins with known functions in atherogenesis (30, 44, 45). The gene discussed is IL1B; the disease is atherosclerosis.